Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS) - Kakkar,A.K.; Levine,M.N.; Kadziola,Z. (J Clin Oncol, 2004)